Day: November 14, 2022

Pineapple Energy Reports Third Quarter 2022 Financial Results

Pineapple Energy Reports Third Quarter 2022 Financial Results

Increased revenue +31% from Q2 2022 Increased gross profit +58% from Q2 2022 Increased kW sold +105% YoY Increased pending installations +40% from Q2 2022 $10.2 million of cash, restricted cash, and investments Step-function growth going forward from SUNation acquisition MINNETONKA, Minn., Nov. 14, 2022 (GLOBE NEWSWIRE) — Pineapple Energy Inc. (NASDAQ:PEGY), a leading provider of sustainable solar energy and back-up power to households and small businesses, today announced financial results for the third quarter ended September 30, 2022. Results reflect performance of the Hawaiian operations; future results will reflect the SUNation acquisition that closed last week. Pineapple CEO Kyle Udseth commented, “The SUNation acquisition fundamentally transforms Pineapple, launching us on our path of intended growth. SUNation triples...

Continue reading

TransCode Therapeutics Reports Third Quarter 2022 Results; Provides Business Update

TransCode Therapeutics Reports Third Quarter 2022 Results; Provides Business Update

BOSTON, Nov. 14, 2022 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today reported financial results for the third quarter ended September 30, 2022, and recent business progress. “We continued to advance our therapeutic programs during the third quarter,” said Michael Dudley, co-founder, president and CEO of TransCode. “We remain on track to achieve our planned milestones for 2H of 2022 which include submission of an exploratory Investigational New Drug Application (eIND) this year for our planned Phase 0 clinical trial in up to 12 cancer patients with advanced solid tumors. We continue to make strides in development of our therapeutic candidates in our pipeline, all of which utilize our proprietary TTX delivery platform....

Continue reading

springbig Reports Third Quarter 2022 Financial Results

springbig Reports Third Quarter 2022 Financial Results

BOCA RATON, Fla., Nov. 14, 2022 (GLOBE NEWSWIRE) — SpringBig Holdings, Inc. (“springbig” or the “Company”) (NASDAQ: SBIG), a leading provider of SaaS-based marketing solutions, consumer mobile app experiences, and omnichannel loyalty programs to the cannabis industry, today announced its financial results for the second quarter ended September 30, 2022.  “Our third quarter results reinforce my view that we are widening the gap as the leading technology loyalty platform across the cannabis sector,” said Jeffrey Harris, CEO and Chairman of springbig. “Acknowledging that cannabis end-markets are experiencing industry specific headwinds, it’s absolutely clear to me that our growth trajectory is intact as we continue to leverage the network effect flywheel between retailers and brands, and that we are making the right investments to...

Continue reading

SAKER AVIATION SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2022

SAKER AVIATION SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2022

Revenue from continuing operations of $2,602,000 in 2022 up 282.5% Versus $680,000 in 2021 Income from continuing operations of $407,000 in 2022 Versus $195,000 in 2021 NEW YORK, Nov. 14, 2022 (GLOBE NEWSWIRE) — Saker Aviation Services, Inc. (OTCQB: SKAS), an aviation services company specializing in ground-based services to the general aviation marketplace, today announced its financial results for the three months ended September 30, 2022. Revenue from continuing operations in the three months ended September 30, 2022 of $2,601,799 was up 282.5 percent from $680,278 in the three months ended September 30, 2021. Income from continuing operations in the three months ended September 30, 2022 of $406,736 was up $211,697 as compared to $195,039 in the same period in 2021. “We are pleased to announce the financial results for the three...

Continue reading

Enthusiast Gaming Announces Third Quarter 2022 Results

Enthusiast Gaming Announces Third Quarter 2022 Results

Revenue of $50.6 million, up 17%YOYRecord gross profit of $16.6 million, up 64%YOYRecord gross margin of 32.7%, up 930 bps YOYRecord direct sales of $10.1 million, up 49% YOYRecord subscription revenue of $3.8 million, up 51% YOY LOS ANGELES, Nov. 14, 2022 (GLOBE NEWSWIRE) — Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (NASDAQ:EGLX; TSX:EGLX), an integrated gaming entertainment company, today announced financial results for the three and nine months ended September 30, 2022. “We are pleased to report that we have achieved yet another record quarter on the back of all-time-highs in key KPIs, including quarterly gross profit, gross margins, direct sales and subscriptions, all despite the macroeconomic headwinds impacting the digital media and entertainment industry,” commented Adrian Montgomery, CEO of Enthusiast...

Continue reading

Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Management to host webcast/conference call today at 2:00 p.m. PT / 5:00 p.m. ET SAN DIEGO, Nov. 14, 2022 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease, today reported financial results for the third quarter of 2022 and provided an update on recent corporate developments. Process Update In October, the Company announced that it had initiated a process to explore a range of strategic and financing alternatives and had retained an investment bank to assist in evaluating certain alternatives focused on maximizing stockholder value. Potential alternatives include a sale, partnership, distribution or other...

Continue reading

Instil Bio Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Instil Bio Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Manufacturing update on voluntary pause of DELTA-1 trial of ITIL-168 in advanced melanoma expected in Q1’23 Reprioritization of resources with enrollment deferred in DELTA-2 trial of ITIL-168 First patient with non-small cell lung cancer dosed with ITIL-306, the first engineered TIL therapy using CoStAR Platform, with plans to share clinical data in 2023 Appointment of cell therapy pioneer Dr. Robert Hawkins as Head of Research and Development, and resignation of Chief Medical Officer, Dr. Zachary Roberts Company confirms cash runway into 2025 with anticipated sale-leaseback transaction of its Tarzana manufacturing facility DALLAS, Nov. 14, 2022 (GLOBE NEWSWIRE) — Instil Bio, Inc. (“Instil”) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment...

Continue reading

Getty Images Reports Third Quarter 2022 Results

Getty Images Reports Third Quarter 2022 Results

NEW YORK, Nov. 14, 2022 (GLOBE NEWSWIRE) —  Getty Images Holdings, Inc. (“Getty Images”) (NYSE: GETY), a preeminent global visual content creator and marketplace, today reported financial results for the third quarter ended September 30, 2022. “Getty Images delivered solid third quarter results, including positive operating performance, purchasing customer growth, and annual subscription growth,” said Craig Peters, Chief Executive Officer of Getty Images. “Despite the challenging macro environment, our customers are deriving more value from us as our paid downloads continue to increase. From what we see, we believe we are taking market share based on the quality of our content offering.” Third Quarter 2022 Financial Summary: Revenue of $230.5 million, down 2.8% year over year. On a currency neutral basis, revenues increased 2.8%. Creative...

Continue reading

CymaBay Reports Third Quarter and Nine Months Ended September 30, 2022 Financial Results and Provides Corporate Update

CymaBay Reports Third Quarter and Nine Months Ended September 30, 2022 Financial Results and Provides Corporate Update

Conference call and webcast today at 4:30 p.m. ET NEWARK, Calif., Nov. 14, 2022 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced corporate updates and financial results for the third quarter ended September 30, 2022. Sujal Shah, President and CEO of CymaBay, stated, “Early in the third quarter we completed enrollment in RESPONSE, our global registration study of seladelpar in patients with PBC. This achievement was a direct result of the tireless efforts of our teams and the relationships we have been fortunate to leverage among partners, health care providers and patient advocacy groups around the world. In addition to clinical presentations highlighting some of the...

Continue reading

ADDvantage Technologies Revenue Increases 31% to $25.9 Million, Record Net Income of $1.5 Million for the Third Quarter of Fiscal 2022

ADDvantage Technologies Revenue Increases 31% to $25.9 Million, Record Net Income of $1.5 Million for the Third Quarter of Fiscal 2022

Record Quarterly EPS of $0.11 vs. $0.05, $5.2 Million in Cash Flow from Operations and $4.9 Million in Cash at September 30 CARROLLTON, Texas, Nov. 14, 2022 (GLOBE NEWSWIRE) — ADDvantage Technologies Group, Inc. (NASDAQ: AEY) (“ADDvantage Technologies” or the “Company”) today reported record financial results for the three and nine months ended September 30, 2022, the third quarter of 2022. The Company has changed its fiscal year end from September 30 to December 31, and this report reflects that adjustment with fiscal year-to-date periods of January 1 to September 30. “Continued double-digit revenue growth, strong demand for our solutions on both sides of our business, and the benefit of cost reduction and margin enhancement initiatives drove record net income for ADDvantage Technologies,” commented Joe Hart, Chief Executive Officer....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.